Capital World Investors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Capital World Investors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-270,000	Closed	-$9.18M	–	638
2021 Q3	$9.18M	Hold	270,000	–	–	﹤0.01%	564
2021 Q2	$9.88M	Hold	270,000	–	–	﹤0.01%	561
2021 Q1	$12.1M	Hold	270,000	–	–	﹤0.01%	536
2020 Q4	$15.4M	Hold	270,000	–	–	﹤0.01%	504
2020 Q3	$13.9M	Hold	270,000	–	–	﹤0.01%	493
2020 Q2	$16.1M	Hold	270,000	–	–	﹤0.01%	453
2020 Q1	$11.1M	Sell	270,000 -217,696	-45%	-$12.1M	﹤0.01%	439
2019 Q4	$30.4M	Buy	487,696 +217,696	+81%	+$10.3M	0.01%	387
2019 Q3	$9.16M	Buy	+270,000	New	+$7.99M	﹤0.01%	473

Other funds holding DCPH

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital World Investors's DCPH Position: Q4 2021 in Review

Capital World Investors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 270,000 shares — an estimated $9.18M sold.

Capital World Investors first reported a position in DCPH in Q3 2019 and held it in 9 quarters. The position peaked at $30.4M in Q4 2019. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Capital World Investors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Capital World Investors sold 270,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $9.18M.
Capital World Investors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 9 quarters.
Capital World Investors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $30.4M in Q4 2019.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Capital World Investors's 13F filing for Q4 2021, filed 14 Feb 2022.